Vulvar squamous cell carcinoma
Clinical trials for Vulvar squamous cell carcinoma explained in plain language.
Never miss a new study
Get alerted when new Vulvar squamous cell carcinoma trials appear
Sign up with your email to follow new studies for Vulvar squamous cell carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a smart drug shrink rare gynecologic tumors?
Disease control Not yet recruitingThis phase II trial tests whether sacituzumab tirumotecan (Sac-TMT) can shrink tumors in people with advanced or metastatic squamous cell carcinoma of the vagina or vulva. These cancers are rare, and there is no standard second-line treatment. Sac-TMT is an antibody-drug conjugat…
Matched conditions: VULVAR SQUAMOUS CELL CARCINOMA
Phase 2 • Sponsor: Latin American Cooperative Oncology Group • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Two-Drug combo aims to shrink vulvar tumors before surgery
Disease control Not yet recruitingThis trial tests whether combining an immune-boosting cream (imiquimod) with a low dose of an immunotherapy drug (nivolumab) can shrink vulvar squamous cell carcinoma tumors before surgery. About 50 women with resectable, early-to-moderate stage vulvar cancer will receive the dru…
Matched conditions: VULVAR SQUAMOUS CELL CARCINOMA
Phase 1/2 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC